Language
  • English (US)
  • Disclosure of Relevant Financial Relationships

    By Speakers, Authors, and Planners of Continuing Educational Activities
  • The intent of this disclosure is to allow the Institute for International Medicine the opportunity to resolve any potential conflicts of interest to assure balance, independence, objectivity and scientific rigor in all of its CME activities.  All planners and faculty of INMED sponsored activities are expected to disclose to INMED any relevant financial relationships with any commercial interest that produces health care goods or services related to the content of the educational activity or presentation in which they are involved with.


    Commercial Interest: any entity producing, marketing, reselling, or distributing health care goods or services consumed by, or used on, patients.  The ACCME  does not consider providers of clinical service directly to patients to be commercial interests.  


    Conflict of Interest: When an individual’s interests are aligned with those of a commercial interest the interests of the individual are in ‘conflict’ with the interests of the public.  


    Financial Relationships: are those relationships in which the individual benefits by receiving a salary, royalty, intellectual property rights, consulting fee, honoraria, ownership interest, or other financial benefit. ACCME considers relationships of the person involved in the CME activity to include financial relationships of a spouse or partner.

    Financial benefits are usually associated with roles such as employment, management position, independent contractor (including contracted research funding where the institution gets the grant and manages the funds and the person is the principal or named investigator on the grant.), consulting, speaking and teaching, membership on advisory committees or review panels, board membership, and other activities from which remuneration is received, or expected. ACCME considers relationships of the person involved in the CME activity to include financial relationships of a spouse or partner.

    For full information on ACCME Standards for Commercial Support click here. 


  •  -  - Pick a Date
    • Open COI = Yes  
    • ___________________________________________________________________________

      TO ALL SPEAKERS AND PLANNERS WHO DOCUMENT A RELEVANT FINANCIAL RELATIONSHIP WITH ANY COMMERCIAL INTEREST THAT PRODUCES HEALTH CARE GOODS OR SERVICES CONCERNED WITH THE CONTENT OF EDUCATION PRESENTATION IN WHICH THEY ARE INVOLVED.

      In an effort to comply with the ACCME requirement to resolve any potential conflicts of interest to assure balance, independence, objectivity and scientific rigor in all CME activities, we are asking that you consider one or more of the following options to assist INMED in its responsibility to ensure appropriate choice of speakers and planners.

      All disclosures will be published to attendees prior to the activity.

    •  
    • Open Presenter/Authors if COI  
    •  

    • Collapse Presenter/Authors if COI  
    • Collapse COI = Yes  
    • Open ALL Planners  
    •  
    • Collapse Planners  
    • Open All Presenters/Authors  

    •  

    • Collapse All Presenters/Authors  
  • Consent to Record

  • Declaration

  • I will uphold academic standards to insure balance, independence, objectivity, and scientific rigor in my role in the planning, development or presentation of this CE activity as follows:

    Presenter/Authors 

    • Teach to the objectives identified for this activity.

    • I will support my presentation and clinical recommendations with the "best available evidence" from the medical literature.

    • Present the source and type or level of evidence (i.e., animal study, RCT, meta-analysis, etc.)

    • Disclose off-label use(s) of any commercial products, services, or devices being presented.  

    • Disclose any relevant financial relationships related to (1) the activity’s content and/or (2) the activity’s supporter/s. 

    • Remove any trade names, or product-group messages from slides, abstracts, or handouts.

    • I will submit my talk in advance for adequate peer review.

    • I will advise CE Department of any changes to my disclosure prior to my presentation.

    Planners

    • To the best of my ability, I will ensure that any speakers or content I suggest is independent of commercial bias.      

    • If requested by the CE Department, I will recuse myself from planning activity content in which I have a conflict of interest.


    In addition, I agree to comply with the requirements to protect health information under the Health Insurance Portability & Accountability Act of 1996. (HIPAA) by de-identifying patient information to protect the privacy of the patient.
    Items to be de-identified include: 1) Names; 2) All elements of dates (except year) [Birth, admission, discharge, death, etc]; 3) Telephone numbers; 4) Fax numbers; 5) Electronic mail addresses; 6) Social security numbers; 7) Medical record numbers; 8) health plan beneficiary numbers; 9) account numbers; 10) certificate/license numbers; 11) vehicle identifiers and serial numbers, including license plate numbers; 12) device identifiers and serial numbers; 13) web universal resource locators (URLs); 14) Internet Protocol (IP) address numbers; 15) Biometric identifiers, including finger and voice prints; 16) full face photographic images and any comparable images; and 17) any other unique identifying number, characteristic, or code.
    Additional information may be requested to resolve any conflict of interest. All identified conflicts of interest will be resolved, and disclosure will be made to activity participants.

    _______________________________________________________________________________

    I agree that my recommendations involving clinical medicine in this CME activity will be based on evidence that is accepted within the profession of medicine as adequate justification for their indications and contraindications in the care of patients. All scientific research referred to, reported or used in support or justification of patient care recommendations will conform to the generally accepted standards of experimental design, data collection and analysis. I further agree to disclose when discussion of an unlabeled use of a project or investigational use not yet approved occurs during the course of the presentation.

  • 0/50
  • Should be Empty: